Results Effects of Acute Pressure Overload on Endocardial Thrombomodulin Expression

Background—Patients with heart failure are at increased risk for thromboembolic events, including stroke. Historically attributed to blood stasis, little is known about the adverse effects of elevated chamber filling pressure on endocardial function, which could predispose to intracardiac thrombus formation. Methods and Results—We investigated changes in the expression of thrombomodulin, a key component of the anticoagulant protein C pathway, in rats subjected to acute atrial pressure overload caused by aortic banding. Acute elevation of left atrial filling pressure, without an associated decline in ventricular systolic function, caused a 70% inhibition of atrial endocardial thrombomodulin expression and resulted in increased local thrombin generation. Targeted restoration of atrial thrombomodulin expression with adenovirus-mediated gene transfer successfully reduced thrombin generation to baseline levels. In vitro co-culture studies revealed that thrombomodulin downregulation is caused by the paracrine release of transforming growth factorfrom cardiac connective tissue in response to mechanical stretch. This was confirmed in vivo by administration of a neutralizing transforming growth factorantibody, which effectively prevented thrombomodulin downregulation during acute pressure overload. Conclusions—These findings suggest that increased hemodynamic load adversely affects endocardial function and is a potentially important contributor to thromboembolus formation in heart failure. (Circulation. 2007;115:67-75.)

[1]  P. ten Dijke,et al.  Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders. , 2005, Chest.

[2]  A. Zuckermann,et al.  Differential Role of TGF‐β1/bFGF and ET‐1 in Graft Fibrosis in Heart Failure Patients , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  J. K. Donahue,et al.  Targeted Modification of Atrial Electrophysiology by Homogeneous Transmural Atrial Gene Transfer , 2005, Circulation.

[4]  S. Rosenkranz TGF-beta1 and angiotensin networking in cardiac remodeling. , 2004, Cardiovascular research.

[5]  A. Kim,et al.  cDNA Cloning of Rabbit Thrombomodulin and Characterization of Gene Expression in Cardiovascular Tissue , 2003, DNA sequence : the journal of DNA sequencing and mapping.

[6]  Y. Iwasaki,et al.  Thrombomodulin and Tissue Factor Pathway Inhibitor in Endocardium of Rapidly Paced Rat Atria , 2003, Circulation.

[7]  G. Dorn,et al.  Transforming growth factor beta in cardiovascular development and function. , 2003, Cytokine & growth factor reviews.

[8]  J. Schaper,et al.  Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human Heart: Structural Deterioration and Compensatory Mechanisms , 2003, Circulation.

[9]  D. Kass,et al.  Wall Tension Is a Potent Negative Regulator of In Vivo Thrombomodulin Expression , 2003, Circulation Research.

[10]  G. Sandusky,et al.  Modulation of Thrombomodulin-dependent Activation of Human Protein C through Differential Expression of Endothelial Smads* , 2002, The Journal of Biological Chemistry.

[11]  J. Gardin,et al.  Outcome of Congestive Heart Failure in Elderly Persons: Influence of Left Ventricular Systolic Function: The Cardiovascular Health Study , 2002, Annals of Internal Medicine.

[12]  R. H. Sohn,et al.  Early Loss of Thrombomodulin Expression Impairs Vein Graft Thromboresistance: Implications for Vein Graft Failure , 2002, Circulation research.

[13]  C. Esmon,et al.  Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis. , 2001, The American journal of pathology.

[14]  C. Esmon,et al.  Dysfunction of endothelial protein C activation in severe meningococcal sepsis. , 2001, The New England journal of medicine.

[15]  G. Lip,et al.  Abnormalities of Hemorheological, Endothelial, and Platelet Function in Patients With Chronic Heart Failure in Sinus Rhythm: Effects of Angiotensin-Converting Enzyme Inhibitor and &bgr;-Blocker Therapy , 2001, Circulation.

[16]  J. Halperin,et al.  Atrial fibrillation and stroke : concepts and controversies. , 2001, Stroke.

[17]  H. Lodish,et al.  Role of transforming growth factor beta in human disease. , 2000, The New England journal of medicine.

[18]  M. Inoue,et al.  Short-term effects of rapid pacing on mRNA level of voltage-dependent K(+) channels in rat atrium: electrical remodeling in paroxysmal atrial tachycardia. , 2000, Circulation.

[19]  A. Takeshita,et al.  Role of transforming growth factor-beta1 in cardiovascular inflammatory changes induced by chronic inhibition of nitric oxide synthesis. , 2000, Hypertension.

[20]  M. Hecker,et al.  Pressure-induced upregulation of preproendothelin-1 and endothelin B receptor expression in rabbit jugular vein in situ : implications for vein graft failure? , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[21]  I. Dixon,et al.  Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. , 1999, Journal of molecular and cellular cardiology.

[22]  L. Fink,et al.  Is the loss of endothelial thrombomodulin involved in the mechanism of chronicity in late radiation enteropathy? , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  M. Domanski,et al.  Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. , 1997, Journal of the American College of Cardiology.

[24]  G. Aurigemma,et al.  Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. , 1995, Circulation.

[25]  K. Higashi,et al.  Transforming Growth Factor Betal and Beta2 Induce Down-Modulation of Thrombomodulin in Human Umbilical Vein Endothelial Cells , 1995, Thrombosis and Haemostasis.

[26]  J. Cohn,et al.  Incidence of Thromboembolic Events in Congestive Heart Failure , 1993, Circulation.

[27]  C. Esmon The protein C anticoagulant pathway. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[28]  H. Schunkert,et al.  Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. , 1990, The Journal of clinical investigation.

[29]  V. Fuster,et al.  Intracardiac thrombi and systemic embolization. , 1986, Annals of internal medicine.

[30]  C. Esmon,et al.  Distribution of the thrombomodulin antigen in the rabbit vasculature. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[31]  C. Bell,et al.  Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta , 1985, The Journal of cell biology.

[32]  V. Fuster,et al.  The natural history of idiopathic dilated cardiomyopathy. , 1981, The American journal of cardiology.

[33]  J. P. Gilmore,et al.  Homeometric Autoregulation in the Heart , 1960, Circulation research.